Search Results - "Takihata, Yasuhiro"

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study by Kobayashi, Kazuki, Einama, Takahiro, Takihata, Yasuhiro, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Kouzu, Keita, Nakazawa, Akiko, Iwasaki, Toshimitsu, Ueno, Hideki, Kishi, Yoji

“…S-1 adjuvant chemotherapy is the standard treatment in Asia for resectable pancreatic ductal adenocarcinoma. The relative dose intensity of adjuvant…”
Get full text

Impact of Lymph Node Metastases Around the Superior Mesenteric Artery on Postoperative Outcomes of Pancreatic Head Cancer by Miyata, Yoichi, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Takihata, Yasuhiro, Iwasaki, Toshimitsu, Einama, Takahiro, Tsujimoto, Hironori, Ueno, Hideki, Yamamoto, Junji, Kishi, Yoji

“…Background The neural plexus and lymph nodes around the superior mesenteric artery (LN#14), are the most frequent sites involved by pancreatic head cancer…”
Get full text

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis by Kakimoto, Soichiro, Miyamoto, Morikazu, Einama, Takahiro, Takihata, Yasuhiro, Matsuura, Hiroko, Iwahashi, Hideki, Ishibashi, Hiroki, Sakamoto, Takahiro, Hada, Taira, Suminokura, Jin, Ito, Tsubasa, Suzuki, Rie, Suzuki, Ayako, Takano, Masashi

“…This study aimed to investigate the association between clinicopathologic factors, mesothelin, and cancer antigen (CA) 125 in endometrial carcinoma. Between…”
Get full text

Utility of Hyperbaric Oxygen Therapy for Acute Acoustic Trauma: 20 years' Experience at the Japan Maritime Self-Defense Force Undersea Medical Center by Oya, Morihiko, Tadano, Yutaka, Takihata, Yasuhiro, Ikomi, Fumitaka, Tokunaga, Tetsuji

“…Abstract Introduction  Acute acoustic trauma, which is a kind of sensorineural hearing loss, is caused by acoustic overstimulation. Hyperbaric oxygen therapy…”
Get full text

IgG4-related hepatic inflammatory pseudotumor mimicking cholangiolocellular carcinoma by Itazaki, Yujiro, Einama, Takahiro, Konno, Fukumi, Fujinuma, Ibuki, Takihata, Yasuhiro, Iwasaki, Toshimitu, Ogata, Sho, Tsujimoto, Hironori, Ueno, Hideki, Kishi, Yoji

“…Inflammatory pseudotumor (IPT) is a benign tumor mass composed of chronic infiltration of inflammatory cells and fibrous tissue. IgG4-RD (related disease) in…”
Get full text

Effects of hyperbaric conditions on fecal microbiota by OYA, Morihiko, TADANO, Yutaka, TAKIHATA, Yasuhiro, MURAKAMI, Wakana, FUJII, Shigenori, TAMAI, Kenji, MORIMOTO, Yuji, IKOMI, Fumitaka, TOKUNAGA, Tetsuji

“…We aimed to determine whether the composition of the fecal microbiota changes under hyperbaric conditions. In this study, we collected fecal samples from 6…”
Get full text

Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma by Takihata, Yasuhiro, Einama, Takahiro, Kobayashi, Kazuki, Suzuki, Takafumi, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Yamagishi, Yoji, Iwasaki, Toshimitsu, Miyata, Yoichi, Shinto, Eiji, Ogata, Sho, Tsujimoto, Hironori, Ueno, Hideki, Kishi, Yoji

“…Recent studies have suggested that the interaction of mesothelin (MSLN) and cancer antigen 125 (CA125) enhances tumor metastases. The aim of the present study…”
Get full text

Destruction of a wandering accessory right hepatic artery in a patient with pancreatic body cancer: a case report by Kikuya, Kenta, Einama, Takahiro, Miyata, Yoichi, Iwasaki, Toshimitsu, Yamagishi, Yoji, Takihata, Yasuhiro, Morimura, Fumio, Edo, Hiromi, Otsuka, Yasuhiro, Mori, Shohei, Tsunenari, Takazumi, Fujinuma, Ibuki, Hirose, Yuichi, Tsujimoto, Hironori, Ueno, Hideki, Kishi, Yoji

“…Aberrant right hepatic arteries are sometimes involved in pancreatic head tumors or accidentally damaged during surgical procedures, which could result in…”
Get full text

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients by Einama, Takahiro, Yamagishi, Yoji, Takihata, Yasuhiro, Suzuki, Takafumi, Yamasaki, Tamio, Hirose, Yuichi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Koga, Makiko, Ishibashi, Yusuke, Nagata, Ken, Shiraishi, Takehiro, Nakazawa, Akiko, Iwasaki, Toshimitsu, Shinto, Eiji, Kato, Kimi, Sato, Kimiya, Ueno, Hideki, Kishi, Yoji, Tsuda, Hitoshi

“…The expression of mesothelin correlates with a poor prognosis in patients with breast cancer. Since mesothelin plays a role in cancer metastasis in association…”
Get full text

In vivo diffuse reflectance spectroscopic analysis of fatty liver with inflammation in mice by Takihata, Yasuhiro, Kawauchi, Satoko, Ogata, Sho, Nishidate, Izumi, Sato, Shunichi, Yamamoto, Junji, Kishi, Yoji

“…Nonalcoholic steatohepatitis is a progressive liver disease that can lead to cirrhosis, hepatocellular carcinoma, and hepatic failure. Thus, the diagnosis of…”
Get full text

Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas by Miyata, Yoichi, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Takihata, Yasuhiro, Hakoda, Hiroyuki, Nakazawa, Akiko, Iwasaki, Toshimitsu, Einama, Takahiro, Togashi, Junichi, Tsujimoto, Hironori, Ueno, Hideki, Beck, Yoshifumi, Kishi, Yoji

“…Background Tumor size (TS) is a well-established prognostic factor of pancreatic ductal adenocarcinoma (PDAC). However, whether a uniform treatment strategy…”
Get full text

Risk of hepatic steatosis with the preoperative treatment of pancreatic cancer and the short-term postoperative outcomes by Kobayashi, Kazuki, Kishi, Yoji, Tsunenari, Takazumi, Yonamine, Naoto, Takihata, Yasuhiro, Nakazawa, Akiko, Takao, Mikiya, Einama, Takahiro, Tsujimoto, Hironori, Ueno, Hideki

“…We investigated whether the preoperative treatment of patients with pancreatic cancer is a risk factor for hepatic steatosis (HS), and whether preoperative HS…”
Get full text

Pancreatic cancer with liver metastasis maintaining complete response with gemcitabine monotherapy: A case report by Ohara, Mayuko, Tsunenari, Takazumi, Einama, Takahiro, Ichio, Koki, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Takihata, Yasuhiro, Takao, Mikiya, Nakazawa, Akiko, Kajiwara, Yoshiki, Ueno, Hideki, Kishi, Yoji

“…Pancreatic ductal adenocarcinoma (PDAC) is associated with a poor prognosis, and it has a recurrence rate of >70%, even in resectable cases. The treatment…”
Get full text

Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study by Kobayashi, Kazuki, Einama, Takahiro, Tsunenari, Takazumi, Yonamine, Naoto, Takao, Mikiya, Takihata, Yasuhiro, Tsujimoto, Hironori, Ueno, Hideki, Tamura, Katsumi, Ishida, Jiro, Kishi, Yoji

“…Tumor resectability, which is increasingly determined based on preoperative chemotherapy, is critical in determining the best treatment for pancreatic cancers…”
Get full text

Prognosis of Pancreatic Cancer Based on Resectability: A Single Center Experience by Einama, Takahiro, Takihata, Yasuhiro, Aosasa, Suefumi, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Nakazawa, Akiko, Shinto, Eiji, Ueno, Hideki, Kishi, Yoji

“…Although conversion surgery has increasingly been performed for initially unresectable advanced pancreatic ductal adenocarcinoma (PDAC), the rate of…”
Get full text

Clinical Impact of Dual Time Point 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer by Einama, Takahiro, Yamagishi, Yoji, Takihata, Yasuhiro, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Kouzu, Keita, Nakazawa, Akiko, Iwasaki, Toshimitsu, Shinto, Eiji, Ishida, Jiro, Ueno, Hideki, Kishi, Yoji

“…We examined the value of preoperative dual time point (DTP) 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (FDG PET/CT)…”
Get full text

Clinical Impact of Dual Time Point 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer by Einama, Takahiro, Yamagishi, Yoji, Takihata, Yasuhiro, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Kouzu, Keita, Nakazawa, Akiko, Iwasaki, Toshimitsu, Shinto, Eiji, Ishida, Jiro, Ueno, Hideki, Kishi, Yoji

“…We examined the value of preoperative dual time point (DTP) 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (FDG PET/CT)…”
Get full text

Ruptured large hepatic cyst with elevated serum and ascites CA19-9 level by Mizukami, Ryosuke, Nakazawa, Akiko, Einama, Takahiro, Kariya, Risa, Ohara, Mayuko, Ichio, Koki, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Takihata, Yasuhiro, Takao, Mikiya, Shinto, Eiji, Ueno, Hideki, Kishi, Yoji

“…Abstract Tumor markers such as carbohydrate antigen 19-9 (CA19-9) are generally useful in ruling out malignancy of hepatic cysts. The patient was a 72-year-old…”
Get full text

Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal‑type breast cancer by Suzuki, Takafumi, Yamagishi, Yoji, Einama, Takahiro, Koiwai, Tomomi, Yamasaki, Tamio, Fukumura-Koga, Makiko, Isfhibash, Yusuke, Takihata, Yasuhiro, Shiraisfh, Takehiro, Miyata, Yoichi, Iwasaki, Toshimitsu, Shinto, Eiji, Sato, Kimiya, Ueno, Hideki, Yamamoto, Junji, Kishi, Yoji, Tsuda, Hitoshi

“…Mesothelin is expressed in various types of malignant tumors. The present study immunohistochemically investigated mesothelin expression and its…”
Get full text

Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report by Sota, Yuki, Einama, Takahiro, Kobayashibayashi, Kazuki, Fujinuma, Ibuki, Tsunenari, Takazumi, Takihata, Yasuhiro, Iwasaki, Toshimitsu, Miyata, Yoichi, Okamoto, Koichi, Kajiwara, Yoshiki, Shinto, Eiji, Tsujimoto, Hironori, Yasuda, Shigeo, Isozaki, Yuka, Yamada, Shigeru, Yamamoto, Junji, Ueno, Hideki, Kishi, Yoji

“…Long-term outcomes after surgical resection of bile duct cancer remain unsatisfactory, and survival, particularly after tumor recurrence, is poor. Gemcitabine…”
Get full text